Ceri Rowe, Alice J. Sitch, Jonathan Barratt, Elizabeth A. Brettell, Paul Cockwell, R Neil Dalton, Jon J. Deeks, Gillian Eaglestone, Tracy Pellatt-Higgins, Philip A. Kalra, Kamlesh Khunti, Fiona C. Loud, Frances S. Morris, Ryan S. Ottridge, Paul E. Stevens, Claire C. Sharpe, Andrew J. Sutton, Maarten W. Taal, Edmund J. Lamb, on behalf of the e GFR-C study group. Biological variation of measured and estimated GFR in patients with chronic kidney disease. Kidney International, Volume 96, Issue 2, pages 429-435, August 2019, https://doi.org/10.1016/j.kint.2019.02.021.
Webb NJ, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN et al. Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT. Health Technology Assessment. 2019 Jun 3;23(26):1-109. https://doi.org/10.3310/hta23260
Webb NJA, Woolley R, Lambe T, Frew E, Brettell E, Barsoum E et al. Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: Phase III randomised controlled trial and economic evaluation. BMJ. 2019 May 23;365. l1800. https://doi.org/10.1136/bmj.l1800
Kyte D, Bishop J, Brettell E, et al. Use of an electronic patient-reported outcome measure in the management of patients with advanced chronic kidney disease: the RePROM pilot trial protocol. BMJ Open 2018;8:e026080. doi: 10.1136/bmjopen-2018-026080
Lambe T, Frew E, Ives NJ, Woolley RL, Cummins C, Brettell EA, Barsoum EN, Webb NJA; PREDNOS Trial Team. Mapping the Paediatric Quality of Life Inventory (PedsQL™) Generic Core Scales onto the Child Health Utility Index-9 Dimension (CHU-9D) Score for Economic Evaluation in Children. Pharmacoeconomics. 2018 Apr;36(4):451-465. doi: 10.1007/s40273-017-0600-7.
Rowe C, Barratt J, Brettell EA, Cockwell P, Dalton RN, Deeks JJ, Kalra PA, Khunti K, Loud F, Ottridge RS, Pellatt-Higgins T, Sitch AJ, Stevens PE, Sharpe CC, Sutton AJ, Taal MW, Lamb EJ on behalf of the eGFR-C study group. Biological variation of measured and estimated GFR in patients with chronic kidney disease. Kidney Week 2016, National Meeting of the Renal Association and the British Renal Society, Birmingham, UK, July 2016
Rowe C, Barratt J, Brettell EA, Cockwell P, Dalton RN, Deeks JJ, Kalra PA, Khunti K, Loud F, Ottridge RS, Pellatt-Higgins T, Sitch AJ, Stevens PE, Sharpe CC, Sutton AJ, Taal MW, Lamb EJ on behalf of the eGFR-C study group. Biological variation of measured and estimated GFR in patients with chronic kidney disease.Focus 2016, National Meeting of the Association for Clinical Biochemistry and Laboratory Medicine, Warwick, UK, April 2016
Natalie Ives, Samir Mehta, Elizabeth Brettell, Marie Valente, Sunil Bhandari. Analysis of continuous biochemical parameters in long-term trials of chronic disease where outcomes could be affected by further intervention. Trials 2015,16(Suppl 2):P62
Sunil Bhandari; Natalie Ives; Elizabeth A. Brettell; Marie Valente; Paul Cockwell; Peter S. Topham; John G. Cleland; Arif Khwaja; Meguid El Nahas; Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial. Nephrology Dialysis Transplantation (2016) 31: 255–261.
T Justin Clark, Lee J Middleton, Natalie Am Cooper, Lavanya Diwakar, Elaine Denny, Paul Smith, Laura Gennard, Lynda Stobert, Tracy E Roberts, Versha Cheed, Tracey Bingham, Sue Jowett, Elizabeth Brettell, Mary Connor, Sian E Jones, Jane P Daniels. A randomised controlled trial of Outpatient versus inpatient Polyp Treatment (OPT) for abnormal uterine bleeding. HEALTH TECHNOLOGY ASSESSMENT VOLUME 19 ISSUE 61 JULY 2015 ISSN 1366-5278.
Bhandari S, Ives N, Brettell EA, Valente M, Cockwell P, Topham PS et al. Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial. Nephrology, Dialysis, Transplantation. 2015 Sep 30. https://doi.org/10.1093/ndt/gfv346
Lamb EJ, Brettell EA, Cockwell P, Dalton N, Deeks J, Harris K et al. The eGFR-C study: Accuracy of glomerular filtration rate (GFR) estimation using creatinine and cystatin C and albuminuria for monitoring disease progression in patients with stage 3 chronic kidney disease - Prospective longitudinal study in a multiethnic population. BMC Nephrology. 2014 Jan 14;15(1). 13. https://doi.org/10.1186/1471-2369-15-13
Gray R, Bentham P, Hills R, Lendon C, Raftery J, Brettell E et al. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet. 2004 Jun 26;363:2105-2115. https://doi.org/10.1016/S0140-6736(04)16499-4